Generics

House Democrats have secured multiple policy changes in the USMCA, including those related to prescription drug pricing,

Afinitor 2.5 mg, 5 mg and 7 mg tablets had a market value of roughly $412 million over the last four quarters, according to IQVIA.

Amgen's biosimilar Avsola offers a biological treatment option to patients across critical disease states, including chronic inflammatory conditions.

The FDA has approved three applications for first generics of Novartis’ Gilenya (fingolimod) capsules for relapsing forms of multiple sclerosis in adult patients.

Exjade had a market value of roughly $113 million and Jadenu had a market value of about $470 million for the most recent 12 months ended in September.

Blink Health is offering new patients more than 4,000 medications for free.

Erlotinib has a market value of approximately $150 million annually, according to sales data.

Amneal has received the Food and Drug Administration’s clearance for three generics that it is introducing immediately, including the first generic of Carafate (sucralfate oral suspension).